FAE — Faes Farma SA Income Statement
0.000.00%
- €1.29bn
- €1.24bn
- €493.65m
- 95
- 53
- 94
- 97
Annual income statement for Faes Farma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 380 | 399 | 439 | 451 | 494 |
Cost of Revenue | |||||
Gross Profit | 240 | 252 | 282 | 297 | 327 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 293 | 305 | 337 | 348 | 387 |
Operating Profit | 86.8 | 93.3 | 101 | 103 | 107 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 84.9 | 93 | 101 | 103 | 108 |
Provision for Income Taxes | |||||
Net Income After Taxes | 73.4 | 82.4 | 89.5 | 91.7 | 111 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 72.5 | 82.4 | 89.5 | 91.9 | 111 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 72.5 | 82.4 | 89.5 | 91.9 | 111 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.244 | 0.26 | 0.284 | 0.296 | 0.359 |
Dividends per Share |